AnaptysBio Total Assets from 2010 to 2024

ANAB Stock  USD 22.52  1.14  5.33%   
AnaptysBio's Total Assets are increasing over the years with slightly volatile fluctuation. Total Assets are expected to dwindle to about 354.3 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2013-12-31
Previous Quarter
487.3 M
Current Value
452.4 M
Quarterly Volatility
210.5 M
 
Yuan Drop
 
Covid
Check AnaptysBio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AnaptysBio main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 M, Interest Expense of 19 M or Selling General Administrative of 44 M, as well as many exotic indicators such as Price To Sales Ratio of 31.93, Dividend Yield of 0.0162 or Operating Cycle of 153. AnaptysBio financial statements analysis is a perfect complement when working with AnaptysBio Valuation or Volatility modules.
  
This module can also supplement AnaptysBio's financial leverage analysis and stock options assessment as well as various AnaptysBio Technical models . Check out the analysis of AnaptysBio Correlation against competitors.
For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.

Latest AnaptysBio's Total Assets Growth Pattern

Below is the plot of the Total Assets of AnaptysBio over the last few years. Total assets refers to the total amount of AnaptysBio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AnaptysBio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. AnaptysBio's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AnaptysBio's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 452.39 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

AnaptysBio Total Assets Regression Statistics

Arithmetic Mean260,631,473
Geometric Mean80,600,847
Coefficient Of Variation93.74
Mean Deviation222,031,909
Median329,364,000
Standard Deviation244,303,803
Sample Variance59684.3T
Range639.2M
R-Value0.86
Mean Square Error17044.1T
R-Squared0.73
Significance0.000044
Slope46,828,238
Total Sum of Squares835580.9T

AnaptysBio Total Assets History

2024354.3 M
2023452.4 M
2022610.4 M
2021643.1 M
2020416.6 M
2019435.2 M
2018509 M

About AnaptysBio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AnaptysBio income statement, its balance sheet, and the statement of cash flows. AnaptysBio investors use historical funamental indicators, such as AnaptysBio's Total Assets, to determine how well the company is positioned to perform in the future. Although AnaptysBio investors may use each financial statement separately, they are all related. The changes in AnaptysBio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AnaptysBio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AnaptysBio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AnaptysBio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Total Assets452.4 M354.3 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AnaptysBio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AnaptysBio's short interest history, or implied volatility extrapolated from AnaptysBio options trading.

Pair Trading with AnaptysBio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AnaptysBio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will appreciate offsetting losses from the drop in the long position's value.

Moving against AnaptysBio Stock

  0.7VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.58MGTX MeiraGTx Holdings PLC Financial Report 9th of May 2024 PairCorr
  0.54MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.42ME 23Andme HoldingPairCorr
The ability to find closely correlated positions to AnaptysBio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AnaptysBio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AnaptysBio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AnaptysBio to buy it.
The correlation of AnaptysBio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AnaptysBio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AnaptysBio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AnaptysBio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AnaptysBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AnaptysBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anaptysbio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anaptysbio Stock:
Check out the analysis of AnaptysBio Correlation against competitors.
For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.
Note that the AnaptysBio information on this page should be used as a complementary analysis to other AnaptysBio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for AnaptysBio Stock analysis

When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is AnaptysBio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnaptysBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.08)
Revenue Per Share
0.637
Quarterly Revenue Growth
0.323
Return On Assets
(0.18)
Return On Equity
(0.93)
The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AnaptysBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnaptysBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnaptysBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.